Schizoid personality disorder (SzPD) is a Cluster A personality disorder defined by a pervasive pattern of detachment from social relationships and a restricted range of expressed emotion, beginning by early adulthood and present across contexts. Patients rarely present voluntarily; clinicians most often encounter SzPD as an incidental finding during workups for depression, occupational dysfunction, or family-driven consultation. retains SzPD in Section II while the alternative model for personality disorders (AMPD) in Section III reconceptualizes it dimensionally through impairments in self and interpersonal functioning plus pathological traits of detachment. The clinical priority is distinguishing SzPD from , , prodromal , and , because management diverges sharply. No medication is approved for SzPD, and psychotherapy evidence remains limited; the bottom line is careful differential diagnosis, treatment of comorbidity, and patient-paced engagement.
SzPD is among the less common personality disorders in community samples, though prevalence estimates vary widely with method and instrument. Epidemiologic data are sparse compared with borderline or .
Prevalence
- Estimated community prevalence of approximately 3.1% in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), among the higher estimates reported.[1]
- Lower estimates from structured interview studies cluster between 0.5% and 1.7%.[2]
- Prevalence in clinical psychiatric settings is generally low, in part because patients rarely seek care for the disorder itself.[2]
Demographics
- Onset is by early adulthood, with traits often recognizable in adolescence; the disorder is not diagnosed before age 18 in DSM-5-TR.[3]
- Slight male predominance has been reported in some samples, though the sex difference is modest and inconsistent.[1-2]
- Higher rates have been observed among never-married and unemployed adults, reflecting the functional consequences of the trait pattern.[1]
Comorbidity
- Comorbidity with other Cluster A personality disorders, particularly schizotypal and paranoid, is common.[2]
- Major depressive disorder, dysthymia, and occur at elevated rates relative to the general population.[1]
- Substance use disorders are less prevalent than in Cluster B disorders but still elevated compared with non-personality-disordered controls.[1]
- Familial loading for schizophrenia-spectrum disorders is reported, consistent with placement in the schizophrenia spectrum in some classification schemes.[4]
The etiology of SzPD is poorly understood compared with schizophrenia or . Most data come from family and twin studies rather than direct neurobiological investigation.
Genetics
- Family studies show elevated rates of schizophrenia-spectrum disorders, including schizotypal personality disorder, among first-degree relatives of probands with schizophrenia, and overlapping liability has been proposed for SzPD.[4]
- Twin studies of personality disorder dimensions estimate heritability of detachment-related traits in the range of 40% to 60%, though SzPD-specific heritability estimates are imprecise.[5]
- Molecular-genetic data for SzPD specifically are limited; replicated single-gene or genome-wide findings have not been established.[5]
Neurobiology
- Direct neuroimaging studies of SzPD are scarce; most inferences are extrapolated from schizophrenia-spectrum research.[4]
- Hypotheses implicate dopaminergic hypofunction in mesocortical pathways as a basis for diminished social motivation, paralleling negative-symptom models of schizophrenia, though direct evidence in SzPD is lacking.[6]
- Social-cognitive deficits, including reduced theory-of-mind performance, have been reported but overlap substantially with autism spectrum disorder.[7]
Environmental and developmental factors
- Retrospective reports describe cold, neglectful, or emotionally impoverished early environments in some patients, but these findings are confounded by recall bias and parental psychopathology.[2]
- The DSM-5-TR cautions against diagnosing SzPD in individuals whose detachment is better explained by autism spectrum disorder, psychotic disorder, or another mental disorder.[3]
SzPD sits at a contested boundary with autism spectrum disorder. The clinical question is whether detachment reflects a lack of interest in relationships (SzPD) or impaired capacity for social communication despite interest (ASD).[7]
DSM-5-TR places SzPD in Cluster A ("odd or eccentric") alongside paranoid and schizotypal personality disorders. The criteria require a pervasive pattern of social detachment and restricted emotional expression beginning by early adulthood and present across contexts.[3]
DSM-5-TR Criterion A (paraphrased)
- Four or more of the following, beginning by early adulthood and present across contexts:[3]
- Neither desires nor enjoys close relationships, including family.[3]
- Almost always chooses solitary activities.[3]
- Little or no interest in sexual experiences with another person.[3]
- Takes pleasure in few, if any, activities.[3]
- Lacks close friends or confidants other than first-degree relatives.[3]
- Appears indifferent to praise or criticism.[3]
- Shows emotional coldness, detachment, or flattened affectivity.[3]
Criteria B and C (exclusions)
- The disturbance does not occur exclusively during the course of schizophrenia, a bipolar or depressive disorder with psychotic features, another psychotic disorder, or autism spectrum disorder, and is not attributable to the physiological effects of another medical condition.[3]
- If criteria are met prior to the onset of schizophrenia, the qualifier "premorbid" is added.[3]
DISTANT
Detached affect, Indifferent to praise/criticism, Sexual disinterest, Tasks solitary, Absent close friends, No pleasure (), Tepid emotional range.
ICD-11 considerations
- abolished categorical personality disorder subtypes and replaced them with a dimensional model rated by severity (mild, moderate, severe) plus trait qualifiers; detachment is one of the trait domains and approximates the SzPD construct.[8]
- A clinician documenting under ICD-11 would record personality disorder with the detachment trait qualifier rather than SzPD as a discrete entity.[8]
DSM-5-TR alternative model (Section III)
- The alternative model for personality disorders (AMPD) operationalizes SzPD through moderate or greater impairment in self and interpersonal functioning plus pathological traits of detachment (withdrawal, intimacy avoidance, anhedonia) and may include restricted affectivity.[3]
- The AMPD is offered as an alternative for clinical and research use and is not the default diagnostic system.[3]
The prototypical patient is a self-described loner who functions adequately in solitary roles and reports neither distress about isolation nor desire for change. Insight into the pattern is variable, and motivation for treatment is typically low.[2]
Core presentation
- Preference for solitary activities (reading, computer work, mechanical or technical hobbies) sustained over decades.[2]
- Limited or absent romantic and sexual interest; lifelong celibacy is not unusual.[2]
- Flat or ; speech is often monotone and brief.[2]
- Apparent indifference to social feedback, which others may experience as cold or aloof.[3]
- Adequate reality testing distinguishes SzPD from schizophrenia and from the or perceptual distortions of schizotypal personality disorder.[3]
Course
- Traits are typically stable across adulthood, consistent with personality disorder definitions, though some attenuation of severity is described in older adults.[2]
- Decompensation under acute stress is uncommon; brief psychotic episodes are rare but can occur.[3]
- Occupational function is often preserved in solitary roles (night-shift work, technical fields, remote employment); interpersonal demands precipitate dysfunction.[2]
Atypical presentations
- Some patients report a rich inner fantasy life that compensates for the absence of external relationships; this is descriptive, not a DSM criterion.[2]
- A subset present after a precipitant such as job loss or of the sole figure (often a parent), revealing the fragility of an apparently stable adjustment.[2]
The differential turns on whether detachment reflects choice (SzPD), incapacity (autism spectrum disorder), fear (avoidant personality disorder), eccentricity with attenuated psychotic features (schizotypal personality disorder), or active psychotic illness. Mistaking SzPD for any of these leads to mismanagement.[3]
Cluster A and psychotic disorders
- Schizotypal personality disorder: differs by the presence of cognitive-perceptual oddities (, magical thinking, illusions) and eccentric behavior or speech.[3]
- Paranoid personality disorder: differs by pervasive distrust and suspiciousness, with intact interest in monitoring others.[3]
- Schizophrenia and other psychotic disorders: positive symptoms, formal thought disorder, and functional decline distinguish active psychosis from stable SzPD traits.[3]
- Prodromal or premorbid schizophrenia: longitudinal observation is required when attenuated symptoms emerge.[3]
Neurodevelopmental and other personality disorders
- Autism spectrum disorder: differentiated by social-communication deficits, restricted and repetitive behaviors, and onset in early development.[3,7]
- Avoidant personality disorder and social anxiety disorder: patients want relationships but fear humiliation or rejection; SzPD patients lack the wish itself.[3,11]
- : detachment, when present, is secondary to rigid devotion to work or rules rather than primary disinterest.[3]
Mood, substance, and medical mimics
- : anhedonia and withdrawal can mimic SzPD, but they emerge episodically and remit with treatment.[3]
- Substance-induced presentations: chronic cannabis or stimulant use can produce amotivation and social withdrawal.[2]
- Medical mimics: hypothyroidism, frontal-lobe lesions, neurodegenerative disease (especially behavioral-variant ), and untreated obstructive sleep apnea can present with and social disengagement.[2]
- Personality change due to another medical condition is coded separately when an identifiable etiology underlies the change.[3]
| Feature | Schizoid PD | Schizotypal PD | Avoidant PD | Autism spectrum disorder |
|---|---|---|---|---|
| Desire for relationships | Absent | Variable, often limited | Strong but feared | Often present, capacity impaired |
| Cognitive-perceptual oddities | Absent | Present (ideas of reference, magical thinking) | Absent | Absent (literal/concrete thinking) |
| Onset | Early adulthood | Early adulthood | Early adulthood | Early developmental period |
| Restricted/repetitive behaviors | Absent | Absent | Absent | Required |
| First-line management | Patient-paced supportive psychotherapy | Psychotherapy; low-dose antipsychotic if attenuated positive symptoms | CBT for social anxiety; SSRI if comorbid | Behavioral/developmental interventions; treat comorbidity |
Assessment combines longitudinal history, collateral information, and exclusion of mimics. Patients rarely volunteer the relevant history; a structured approach prevents under- or overdiagnosis.[2]
Interview approach
- Establish chronicity (across early adulthood and contexts) and pervasiveness; episodic withdrawal points away from a personality disorder.[3]
- Map relationships across life domains: family, friendships, romantic, occupational, recreational.[2]
- Probe the wish for closeness explicitly; SzPD patients describe indifference, avoidant patients describe longing with fear.[2]
- Screen for psychotic symptoms (past and present), substance use, and mood episodes.[3]
- Collateral history from a relative or longstanding contact is often essential, given limited self-report.[2]
Mandatory exclusions
- Active psychotic disorder and mood episode with psychotic features.[3]
- Autism spectrum disorder, including consideration of late-diagnosed presentations in adults; refer for specialist assessment when developmental features are prominent.[3,7,12]
- Substance use sufficient to account for the presentation.[3]
- Medical contributors when atypical (late onset, cognitive change, neurological signs).[2]
Rating scales and structured instruments
- (SCID-5-PD) is the standard research instrument and can be used clinically.[13]
- (PID-5) operationalizes the AMPD trait model, including detachment.[3]
- International Personality Disorder Examination (IPDE) is an alternative semi-structured interview.[13]
Laboratory and imaging
- No diagnostic laboratory or imaging finding exists for SzPD; testing is directed at excluding mimics when clinically indicated.[2]
- Reasonable workup when the presentation is atypical: TSH, vitamin B12, basic metabolic panel, and toxicology; neuroimaging when neurological signs, cognitive decline, or late-onset personality change is present.[2]
- Routine neuroimaging or extensive panels in a typical presentation are not indicated.[2]
No treatment is approved for SzPD, and randomized trials are essentially absent. Management is pragmatic: patient-paced engagement, treatment of comorbidity, and harm reduction. Forcing intimacy or insight in a patient who does not seek either is iatrogenic.[9]
Pharmacotherapy
- No medication is FDA-approved for SzPD; pharmacotherapy targets comorbid mood, anxiety, or attenuated psychotic symptoms rather than core traits.[9]
- Evidence suggests may be considered for comorbid depression or anxiety using standard dosing (e.g., sertraline 50 mg PO QD titrated as tolerated).[14]
- It is uncertain whether low-dose (e.g., risperidone 0.5 mg PO QD) benefit SzPD without comorbid psychotic-spectrum features; data are extrapolated from schizotypal trials and should not be applied indiscriminately.[10]
- Some experts recommend bupropion for prominent Anhedonia or amotivation, though high-quality evidence is lacking.[9]
Psychotherapy
- Limited evidence suggests supportive, patient-paced individual psychotherapy is the modality most patients can tolerate; the alliance itself is often the therapeutic target.[9]
- Cognitive-behavioral therapy adapted for personality disorders has been described, focusing on schemas of detachment and behavioral activation, with limited controlled evidence.[15]
- Psychodynamic and mentalization-based approaches have been applied, but trial-level evidence for SzPD specifically is lacking; most data come from mixed personality-disorder samples.[15]
- Group therapy is generally poorly tolerated early in treatment given the interpersonal demands; it may be introduced selectively after stable individual engagement.[9]
Neuromodulation
- No role for , , or other neuromodulation in SzPD itself; these may be indicated for comorbid by standard criteria.[16]
Adjunctive
- Vocational counseling that matches the patient to solitary or low-demand interpersonal roles can preserve function.[9]
- Psychoeducation for family members about the nature of the trait pattern can reduce conflict and expectations of normative reciprocity.[9]
- Treatment of comorbid substance use disorders follows standard guidelines.[16]
The therapeutic goal is rarely to make a schizoid patient social. Realistic targets are reducing comorbid suffering, preserving function, and maintaining a single reliable clinical contact.[9]
| Intervention | Evidence base/Comparator | Benefits | Harms | Certainty | Notes |
|---|---|---|---|---|---|
| Supportive psychotherapy | Expert opinion, case series; no RCTs in SzPD | Engagement, comorbidity management | Low risk; dropout common | very_low | Patient-paced; alliance is the target[9] |
| CBT adapted for PD | Small uncontrolled studies in mixed PD samples | Possible reduction in dysfunctional schemas | Low risk | very_low | Limited SzPD-specific data[15] |
| SSRIs for comorbid mood/anxiety | Extrapolated from MDD/anxiety trials | Symptomatic relief of comorbidity | GI, sexual, activation | moderate | Treats comorbidity, not core traits[14] |
| Low-dose second-generation antipsychotics | Schizotypal PD trials extrapolated | Possible benefit in attenuated symptoms | Metabolic, EPS, sedation | very_low | Not for core SzPD without justification[10] |
| Group therapy (early) | Clinical experience | Limited | Dropout, increased withdrawal | expert_opinion | Defer until individual engagement is stable[9] |
The principal harm in SzPD care is overtreatment driven by clinician or family discomfort with the patient's chosen isolation. The evidence base is also thin enough that strong claims about efficacy are not warranted.[9]
Treatment-related harms
- SSRI adverse effects include gastrointestinal upset, sexual dysfunction, and activation; sexual side effects are particularly poorly tolerated and worth pre-emptive discussion.[14]
- Second-generation antipsychotics carry metabolic risk (weight gain, dyslipidemia, hyperglycemia), , and sedation; their use in SzPD without comorbid indication is not supported by strong evidence.[10]
- Forced group or intensive interpersonal therapy can precipitate dropout and worsen withdrawal.[9]
Diagnostic harms
- Misdiagnosing autism spectrum disorder as SzPD denies the patient access to developmental supports and accurate self-understanding.[7]
- Misdiagnosing prodromal schizophrenia as SzPD delays early intervention.[3]
- Overdiagnosing SzPD in introverted but non-disordered individuals pathologizes normal variation.[3]
Evidence limitations
- Randomized controlled trials specific to SzPD are essentially absent; most recommendations rest on expert opinion and extrapolation from related disorders.[9]
- Longitudinal studies of stability and outcome are limited and confounded by diagnostic instability over time.[2]
- Most epidemiologic estimates derive from a small number of large surveys, with wide variation in instruments and definitions.[1-2]
Diagnostic and management considerations vary across the lifespan and across comorbidity profiles. The diagnosis is not made before age 18 in DSM-5-TR, and presentations in older adults and culturally diverse populations require care.[3]
Pediatric and adolescent
- Personality disorder diagnosis before age 18 requires features present for at least one year and is not given for SzPD in DSM-5-TR; differential focuses on autism spectrum disorder, , and emerging psychotic illness.[3]
- Childhood traits of social withdrawal may attenuate or persist; longitudinal observation is preferred over premature labeling.[2]
Geriatric
- Late-onset social withdrawal should not be ascribed to SzPD; consider major (particularly behavioral-variant frontotemporal dementia), late-life depression, and sensory impairment.[2]
- Long-standing SzPD may attenuate in severity, though core preferences typically persist.[2]
Perinatal
- Specific perinatal data for SzPD are not available; manage as for any patient with limited social support by screening for comorbid perinatal depression and arranging low-demand follow-up.[9]
Cultural considerations
- Norms for self-disclosure, eye contact, and relational interdependence vary across cultures; what looks like detachment may reflect cultural style or immigration-related isolation rather than SzPD.[3]
- Religious or contemplative vocations (monastic life, eremitic practice) emphasize solitude as a value and should not be pathologized.[3]
Comorbid medical or substance use
- Chronic cannabis use can mimic or exacerbate the amotivational and withdrawn presentation; reassess after a period of abstinence when feasible.[2]
- Manage comorbid medical illness with attention to the patient's preference for minimal interpersonal contact (e.g., asynchronous communication, longer appointment intervals when safe).[9]
SzPD is among the more stable personality disorders longitudinally, though diagnostic stability is imperfect and functional outcome varies. Most patients do not present for treatment and remain undiagnosed throughout life.[2]
Course and stability
- Trait detachment is generally stable across adulthood; categorical diagnostic stability over years is moderate, in part reflecting category limitations.[2]
- A minority of patients later meet criteria for a schizophrenia-spectrum disorder, particularly those with attenuated psychotic features at baseline.[4]
Functional outcome
- Occupational outcomes depend heavily on role fit; solitary technical or skilled-trade roles can support full function, while interpersonal or service roles are typically poorly tolerated.[2]
- Marital and family outcomes are commonly limited; rates of long-term partnership are lower than population norms.[1]
Mortality and suicide
- Suicide risk in SzPD is elevated relative to community baseline, driven primarily by comorbid depression and substance use rather than the personality disorder itself; precise estimates are limited.[2]
Acute presentations in SzPD usually reflect comorbid mood, psychotic, or substance-related crises rather than the personality disorder itself. Standard emergency assessment applies, with attention to features specific to detached, low-engagement patients.[2]
Hospitalization criteria
- Hospitalize for the comorbid condition (suicidal depression, emergent psychosis, severe substance withdrawal) following standard criteria; SzPD itself is not an indication for admission.[2]
- The inpatient milieu's interpersonal demands can be poorly tolerated; minimize forced group participation and protect a single point of contact when possible.[9]
Suicide risk
- Isolation, limited social supports, and absent help-seeking are recognized risk markers; SzPD often combines all three.[16]
- Assess for the emergence of psychotic symptoms, especially command , when an apparently stable patient presents acutely.[3]
Do not interpret a SzPD patient's flat affect or low expressed distress as low suicide risk; affective constriction can mask intent, and standard risk assessment applies.[16]
Agitation and de-escalation
SzPD sits at several conceptual fault lines: its boundary with autism spectrum disorder, its placement within the schizophrenia spectrum, and the larger shift from categorical to dimensional models of personality pathology.[3]
Boundary with autism spectrum disorder
- Whether some adults currently labeled SzPD have unrecognized autism spectrum disorder is an active question, with implications for support services and self-understanding.[7]
- The distinction (disinterest versus impaired capacity) is clinically meaningful but difficult to operationalize in adults without developmental history.[7]
Categorical versus dimensional classification
- ICD-11 has eliminated categorical personality disorder subtypes in favor of severity plus trait domains; DSM-5-TR retains categories in Section II with the AMPD as an alternative in Section III.[3,8]
- The detachment trait domain in both systems may prove more reliable than the SzPD category, though categorical familiarity persists in clinical practice.[8]
Schizophrenia-spectrum placement
- Family-genetic data support partial overlap with schizophrenia liability, but SzPD lacks the cognitive-perceptual features that define schizotypal personality disorder; whether SzPD belongs in the schizophrenia spectrum or as a distinct detachment-trait disorder is debated.[4]
Treatment evidence gap
- The near-absence of randomized trials in SzPD specifically leaves clinicians extrapolating from related disorders; high-quality treatment research is a priority but difficult given low treatment-seeking.[9]
- SzPD is a Cluster A personality disorder defined by pervasive social detachment and restricted affect, present by early adulthood and across contexts.[3]
- Diagnosis requires four or more of seven DSM-5-TR criteria and exclusion of psychotic, autism spectrum, and bipolar/depressive-with-psychotic-features disorders.[3]
- SzPD patients neither desire nor enjoy close relationships, distinguishing them from avoidant personality disorder patients who want relationships but fear them.[3]
- Schizotypal personality disorder is distinguished from SzPD by the presence of cognitive-perceptual oddities and eccentric behavior.[3]
- Autism spectrum disorder is distinguished by social-communication deficits, restricted/repetitive behaviors, and early-developmental onset.[3,7]
- The premorbid qualifier is added when SzPD criteria precede the onset of schizophrenia.[3]
- No medication is FDA-approved for SzPD; pharmacotherapy targets comorbid mood, anxiety, or psychotic-spectrum symptoms.[9]
- First-line management is patient-paced supportive psychotherapy with realistic functional goals.[9]
- ICD-11 replaces categorical personality disorder subtypes with severity and trait qualifiers, including detachment.[8]
- The AMPD in DSM-5-TR Section III defines SzPD by impairment in self/interpersonal functioning plus detachment trait domain features.[3]
- Family studies show elevated schizophrenia-spectrum disorders in first-degree relatives of probands.[4]
- Late-onset social withdrawal should prompt evaluation for behavioral-variant frontotemporal dementia, late-life depression, and sensory impairment rather than a new SzPD diagnosis.[2]
- Flat affect in SzPD can mask suicidal ideation; standard risk assessment applies regardless of expressed distress.[16]
- Personality disorder diagnosis is generally not made before age 18, and SzPD is not diagnosed in childhood.[3]
No external funding. No conflicts of interest declared. Peer-review status: pending.
- 1.Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2004;65(7):948-958.
- 2.TextbookSadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. 11th ed. Philadelphia: Wolters Kluwer; 2015.
- 3.TextbookAmerican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, text rev. Washington, DC: American Psychiatric Association Publishing; 2022.
- 4.Kendler KS, McGuire M, Gruenberg AM, et al. The Roscommon Family Study. III. Schizophrenia-related personality disorders in relatives. Arch Gen Psychiatry. 1993;50(10):781-788.
- 5.Torgersen S, Lygren S, Oien PA, et al. A twin study of personality disorders. Compr Psychiatry. 2000;41(6):416-425.
- 6.TextbookStahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 5th ed. Cambridge: Cambridge University Press; 2021.
- 7.Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920):896-910.
- 8.TextbookWorld Health Organization. International Classification of Diseases, 11th Revision (ICD-11). Geneva: WHO; 2019.
- 9.TextbookHales RE, Yudofsky SC, Roberts LW. The American Psychiatric Publishing Textbook of Psychiatry. 7th ed. Washington, DC: American Psychiatric Association Publishing; 2019.
- 10.Koenigsberg HW, Reynolds D, Goodman M, et al. Risperidone in the treatment of schizotypal personality disorder. J Clin Psychiatry. 2003;64(6):628-634.
- 11.GuidelineNational Institute for Health and Care Excellence. Social Anxiety Disorder: Recognition, Assessment and Treatment. NICE Clinical Guideline CG159. London: NICE; 2013.
- 12.GuidelineNational Institute for Health and Care Excellence. Autism Spectrum Disorder in Adults: Diagnosis and Management. NICE Clinical Guideline CG142. London: NICE; 2012.
- 13.TextbookFirst MB, Williams JBW, Benjamin LS, Spitzer RL. Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5-PD). Arlington, VA: American Psychiatric Association Publishing; 2016.
- 14.TextbookSchatzberg AF, DeBattista C. Manual of Clinical Psychopharmacology. 9th ed. Washington, DC: American Psychiatric Association Publishing; 2019.
- 15.Bateman AW, Gunderson J, Mulder R. Treatment of personality disorder. Lancet. 2015;385(9969):735-743.
- 16.GuidelineAmerican Psychiatric Association. Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors. Washington, DC: American Psychiatric Association; 2003.
More on these topics
Obsessive-Compulsive Personality Disorder (OCPD): Diagnosis, Differential, and Evidence-Based Management
A clinical reference on OCPD covering DSM-5-TR criteria, differentiation from OCD, assessment, and evidence-based treatment.
Obsessive-Compulsive Personality DisorderPersonality DisordersDependent Personality Disorder: Diagnosis, Differential, and Management
Evidence-based overview of dependent personality disorder for clinicians: DSM-5-TR criteria, differential diagnosis, assessment, and psychotherapy-first treatment.
Dependent Personality DisorderPersonality DisordersAvoidant Personality Disorder: Diagnosis, Differential, and Evidence-Based Management
A clinical reference on avoidant personality disorder covering DSM-5-TR diagnosis, differentiation from social anxiety disorder, and evidence-based treatment.
Avoidant Personality DisorderPersonality DisordersNarcissistic Personality Disorder: Diagnosis, Differential, and Evidence-Based Management
A clinical reference on narcissistic personality disorder covering DSM-5-TR criteria, differential diagnosis, assessment, and psychotherapy-led management.
Narcissistic Personality DisorderPersonality DisordersHistrionic Personality Disorder: Clinical Features, Diagnosis, and Management
Clinical reference on histrionic personality disorder covering DSM-5-TR criteria, differential diagnosis, evidence-based psychotherapy, and exam-relevant pearls.
Histrionic Personality DisorderPersonality DisordersBorderline Personality Disorder: Diagnosis, Evidence-Based Treatment, and Clinical Management
A clinical reference on borderline personality disorder covering DSM-5-TR diagnosis, differential, evidence-based psychotherapies, and pharmacologic adjuncts.
Borderline Personality DisorderPersonality DisordersAntisocial Personality Disorder: Diagnosis, Assessment, and Management
Clinical reference on antisocial personality disorder covering DSM-5-TR criteria, differential diagnosis, evidence-based treatment, and forensic considerations.
Antisocial Personality DisorderPersonality DisordersSchizotypal Personality Disorder: Diagnosis, Differential, and Management
Clinical overview of schizotypal personality disorder, covering DSM-5-TR criteria, schizophrenia-spectrum biology, differential, and evidence-based management.
Schizotypal Personality DisorderPersonality Disorders